Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 50 /hr
Hire Timeo M.
United Kingdom
USD 50 /hr
Clinical Trial Manager. Provide clinical research expertise for all phase (I to III) trials globally
Profile Summary
Subject Matter Expertise
Services
Writing
Clinical Trial Documentation,
Medical Writing,
Technical Writing
Research
Scientific and Technical Research,
Systematic Literature Review
Consulting
Digital Strategy Consulting,
Healthcare Consulting,
Scientific and Technical Consulting,
Regulatory Consulting
Data & AI
Statistical Analysis,
Data Visualization,
Data Processing,
Data Insights
Work Experience
University of Oxford
- Present ![]()
Clinical Trial Manager
University of Oxford
October 2023 - June 2026 ![]()
Clinical Trials Coordinator
Kamuzu University of Health science (KUHeS)
August 2022 - September 2023
Clinical Trials Coordinator
Malawi Liverpool Welcome research program
December 2020 - July 2022
Research Clinical Officer
Dignitas International Organisation
September 2015 - December 2017
Education
MSc in Clinical Trials (London School of Hygiene and Tropical Medicine (LSHTM))
University Of London
December 2020 - December 2023 ![]()
BSC in Public Health
ShareWorld University
January 2016 - November 2018
Diploma in Clinical Medicine
Malawi Adventist University ( Malamulo College of Health Sciences)
April 2012 - January 2013
Certifications
-
PRINCE2 Practitioner- Project management
PeopleCert
April 2026 - Present
-
Essential guide on grant applications
NIHR
April 2024 - Present
-
Leadership and Management in health
University of Washington
January 2021 - Present
-
Risk Management
Malawi Liverpool Wellcome trust
January 2021 - Present
-
CH-GCP (E6 R3)
NIHR, University of Oxford
January 2026 - December 2026
Publications
JOURNAL ARTICLE
Burke RM, Nyirenda SK, Mtenga T, Twabi HH, Joekes E, Walker NF, Nyirenda R, Gupta-Wright A, Nliwasa M, Fielding K, et al.(2025). Enhanced Tuberculosis Diagnosis With Computer-aided Chest X-ray and Urine Lipoarabinomannan in Adults With HIV Admitted to Hospital (CASTLE Study): A Cluster Randomized Trial . Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
Timeo Mtenga, Rachael M Burke, Saulos K Nyirenda, Hussein H Twabi, Elizabeth Joekes, Naomi F Walker, Rose Nyirenda, Ankur Gupta-Wright, Marriott Nliwasa, Katherine Fielding, et al. (2024). Enhanced Tuberculosis Diagnosis With Computer-aided Chest X-ray and Urine Lipoarabinomannan in Adults With HIV Admitted to Hospital (CASTLE Study): A Cluster Randomized Trial . Clinical Infectious Diseases.
Gerber F, Semphere R, Lukau B, Mahlatsi P, Mtenga T, Lee T, Kohler M, Glass TR, Amstutz A, Molatelle M, et al.(2024). Same-day versus rapid ART initiation in HIV-positive individuals presenting with symptoms of tuberculosis: Protocol for an open-label randomized non-inferiority trial in Lesotho and Malawi . PloS one.
Felix Gerber, Robina Semphere, Blaise Lukau, P.A. Mahlatsi, Tristan Lee, Michaela Kohler, Tracy R. Glass, Alain Amstutz, Mamello Molatelle, et al., Timeo Mtenga (2023). Same-day versus rapid ART initiation in HIV-positive individuals presenting with symptoms of tuberculosis: protocol for an open-label randomized non-inferiority trial in Lesotho and Malawi . PLOS ONE.
Timeo Mtenga (2023). The impact of Covid-19 on Tuberculosis (TB) care among admitted medical patients in Zomba, Malawi: a cross-sectional study . The Global Health Network Collections.
PREPRINT
Gerber F, Semphere R, Lukau B, Mahlatsi P, Mtenga T, Lee T, Kohler M, Glass TR, Amstutz A, Molatelle M, et al.(2023). Same-day versus rapid ART initiation in HIV-positive individuals presenting with symptoms of tuberculosis: protocol for an open-label randomized non-inferiority trial in Lesotho and Malawi .
RESEARCH TECHNIQUE
Timeo Mtenga, Oliver FitzGerald, Laura Coates, Stephen R. Pennington, Teresa Grohmann, Michaela Koehm, Rudolf Horvath, Mari Hoff, Burkhard Moller, Theodoros Dimitroulas The protocol of a patient-driven on-line prospective European observational cohort aiming to determine risk factors for the development of psoriatic arthritis (PsA) amongst people living with psoriasis:.